← Open Payments lookup

JENNA BOSCH: Open Payments

NPI 1700208071 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$886 in 51 payments from 8 companies in 2025. Trend: 2023 $350 · 2024 $612 · 2025 $886

Food & beverage: $886
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP14$256
Amgen Inc.10$146
ABBVIE INC.9$139
Novo Nordisk Inc5$110
Esperion Therapeutics, Inc.6$94
PFIZER INC.3$73
Lilly USA, LLC2$36
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$31

Products named: FARXIGA, REPATHA, NEXLETOL, Ozempic, AIRSUPRA, QULIPTA, UBRELVY, ELIQUIS.

Industry payments across AL — which companies pay providers there.